Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2020 12:00 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders

Scheduled to Reconvene on December 16, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
November 11, 2020 10:54 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders

Scheduled to Reconvene on November 25, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
October 22, 2020 11:25 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders

Scheduled to Reconvene on November 11, 2020Company Urgently Encourages Stockholders to Vote BUENA, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based...
September 23, 2020 08:50 ET | Source: Teligent, Inc.

Teligent Announces Completion of Series D Convertible Note Exchange

BUENA, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the...
August 19, 2020 07:30 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Second Quarter 2020 Results

BUENA, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second...
August 14, 2020 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Second Quarter 2020 Financial Results and Business Update on Wednesday August 19th, 2020

BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on...
July 20, 2020 16:05 ET | Source: Teligent, Inc.

Teligent Announces Completion of Series C Convertible Note Financing and Exchange

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the...
July 20, 2020 08:45 ET | Source: Teligent, Inc.

Teligent, Inc. Announces the Appointment of John Celentano as Chairman of the Board

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that...
July 17, 2020 08:45 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Hiring of Chief Legal Officer and Corporate Secretary

BUENA, N.J., July 17, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced the hiring of...
June 22, 2020 16:15 ET | Source: Teligent, Inc.

Teligent Regains Compliance with NASDAQ Listing Requirements

BUENA, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that it...